Stockreport

Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial [Yahoo! Finance]

Dynavax Technologies Corporation  (DVAX) 
Last dynavax technologies corporation earnings: 3/11 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.dynavax.com
PDF Newly presented data outline robust polyfunctional CD4+ T-cell responses in Z-1018 arms Company initiates Part 2 of Phase 1/2 head-to-head versus Shingrix in adults 7 [Read more]